Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

OBPM_COYOTE2024 Physiological Data Recording With the Calibration-free Optical Aktiia G2C Device at Fingertip and Wrist, Alongside the Aktiia Oscillometric Cuff

OBPM_COYOTE2024 Physiological Data Recording With the Calibration-free Optical Aktiia G2C Device at Fingertip and Wrist, Alongside the Aktiia Oscillometric Cuff: a Single-center, Prospective Clinical Study

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The present study, OBPM\_COYOTE2024, with N = 255 participants minimum over 1 visit (lasting \~15min), has been designed to collect raw optical data with Aktiia.product-G2C Clinical investigational device together with Aktiia G2 Bracelet and Aktiia Init I1 oscillometric cuff within a cohort of subjects characterized by a wide variety of phenotypes. The resulting dataset will support research and development activities conducted by AKTIIA SA out of the study context.

Who May Be Eligible (Plain English)

Who May Qualify: - Subjects aged 21 to 85yo - Subjects or witnesses fluent in written and spoken French - Subjects agreeing to attend the study visit and follow study procedures - Subjects that have signed the willing to sign a consent form form. Who Should NOT Join This Trial: - Amputated index fingers - Damaged/injured skin at index fingers - Damaged/injured skin at wrists - Subjects with tachycardia (heart rate at rest \> 120bpm) - Subjects with atrial fibrillation - Subjects with diabetes - Subjects with marked renal dysfunctions (eGFR \< 30mL/min/1.73 m2) - Subjects with untreated hyper-/hypothyroidism - Subjects with pheochromocytoma - Subjects with Raynaud's disease - Subjects with an arteriovenous fistula - Women in known pregnancy - History of polyneuropathy Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Subjects aged 21 to 85yo * Subjects or witnesses fluent in written and spoken French * Subjects agreeing to attend the study visit and follow study procedures * Subjects that have signed the informed consent form. Exclusion Criteria: * Amputated index fingers * Damaged/injured skin at index fingers * Damaged/injured skin at wrists * Subjects with tachycardia (heart rate at rest \> 120bpm) * Subjects with atrial fibrillation * Subjects with diabetes * Subjects with marked renal dysfunctions (eGFR \< 30mL/min/1.73 m2) * Subjects with untreated hyper-/hypothyroidism * Subjects with pheochromocytoma * Subjects with Raynaud's disease * Subjects with an arteriovenous fistula * Women in known pregnancy * History of polyneuropathy

Treatments Being Tested

DEVICE

Aktiia G2C

Study subjects are asked to stay seated while 3 successive measurements are taken with the Aktiia G2C device under investigation (BP and PR) and two references (Aktiia Bracelet G2 and Aktiia Init I1 oscillometric cuff).

Locations (1)

CHUV Service de Néphrologie et d'Hypertension
Lausanne, Switzerland